| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 6.68e-09 | 4 | 182 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 6.68e-09 | 4 | 182 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 6.68e-09 | 4 | 182 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 3.32e-08 | 5 | 182 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 3.32e-08 | 5 | 182 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 3.32e-08 | 5 | 182 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 3.32e-08 | 5 | 182 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 3.32e-08 | 5 | 182 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 3.32e-08 | 5 | 182 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 3.32e-08 | 5 | 182 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 9.88e-08 | 6 | 182 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 2.29e-07 | 7 | 182 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 4.54e-07 | 8 | 182 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 4.54e-07 | 8 | 182 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 4.54e-07 | 8 | 182 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 8.12e-07 | 9 | 182 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 8.12e-07 | 9 | 182 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.34e-06 | 10 | 182 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.34e-06 | 10 | 182 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 5.92e-06 | 29 | 182 | 5 | GO:0043395 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 6.22e-06 | 14 | 182 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 6.22e-06 | 14 | 182 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.76e-06 | 51 | 182 | 6 | GO:0043394 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 9.82e-06 | 32 | 182 | 5 | GO:0004033 | |
| GeneOntologyMolecularFunction | NADP binding | 2.13e-05 | 62 | 182 | 6 | GO:0050661 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 2.89e-05 | 20 | 182 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 3.02e-05 | 40 | 182 | 5 | GO:0016709 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 6.15e-05 | 24 | 182 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 7.42e-05 | 48 | 182 | 5 | GO:0016620 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 8.53e-05 | 26 | 182 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 8.53e-05 | 26 | 182 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 9.95e-05 | 27 | 182 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 1.16e-04 | 11 | 182 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | organic acid binding | L1CAM GLRA3 SHMT1 AKR1C4 AKR1C1 AKR1C2 RYR2 AKR1C3 SIGLEC11 NOS3 | 1.17e-04 | 254 | 182 | 10 | GO:0043177 |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.52e-04 | 30 | 182 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.56e-04 | 56 | 182 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.99e-04 | 13 | 182 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.22e-04 | 33 | 182 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 2.50e-04 | 34 | 182 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 2.53e-04 | 62 | 182 | 5 | GO:0016627 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 3.57e-04 | 239 | 182 | 9 | GO:0031406 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 4.28e-04 | 39 | 182 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 4.90e-04 | 4 | 182 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 4.90e-04 | 4 | 182 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor binding | 4.90e-04 | 4 | 182 | 2 | GO:0070326 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.49e-04 | 18 | 182 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 8.11e-04 | 5 | 182 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.10e-03 | 127 | 182 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.21e-03 | 6 | 182 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 ABCA2 DNAH10 YTHDC2 CHD4 INO80 ABCA7 ABCC6 UBA7 MYH14 DQX1 ATP6V0A4 DHX35 DNAH11 | 1.54e-03 | 614 | 182 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.68e-03 | 138 | 182 | 6 | GO:0016614 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.78e-03 | 95 | 182 | 5 | GO:0016651 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.06e-03 | 28 | 182 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 2.19e-03 | 60 | 182 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 2.29e-03 | 29 | 182 | 3 | GO:0045499 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK1 ARHGAP15 DOCK10 ARHGAP9 TBC1D8B FARP2 SLIT2 NF1 SRGAP3 ARHGAP12 TNK2 SEC23A | 2.44e-03 | 507 | 182 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK1 ARHGAP15 DOCK10 ARHGAP9 TBC1D8B FARP2 SLIT2 NF1 SRGAP3 ARHGAP12 TNK2 SEC23A | 2.44e-03 | 507 | 182 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 ABCA2 DNAH10 YTHDC2 CHD4 INO80 ABCA7 ABCC6 DQX1 DHX35 DNAH11 | 2.46e-03 | 441 | 182 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 2.85e-03 | 9 | 182 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 2.85e-03 | 9 | 182 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | syndecan binding | 2.85e-03 | 9 | 182 | 2 | GO:0045545 | |
| GeneOntologyMolecularFunction | lncRNA binding | 3.93e-03 | 35 | 182 | 3 | GO:0106222 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 4.08e-03 | 115 | 182 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 4.16e-03 | 279 | 182 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 4.61e-03 | 37 | 182 | 3 | GO:0045505 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 6.00e-09 | 4 | 183 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 6.00e-09 | 4 | 183 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 6.00e-09 | 4 | 183 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 6.00e-09 | 4 | 183 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 2.98e-08 | 5 | 183 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 2.98e-08 | 5 | 183 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 2.98e-08 | 5 | 183 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 2.98e-08 | 5 | 183 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 2.98e-08 | 5 | 183 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 2.98e-08 | 5 | 183 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 8.87e-08 | 6 | 183 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 8.87e-08 | 6 | 183 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 2.06e-07 | 7 | 183 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 2.06e-07 | 7 | 183 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 2.06e-07 | 7 | 183 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 7.30e-07 | 9 | 183 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 9.44e-07 | 21 | 183 | 5 | GO:0048385 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.21e-06 | 10 | 183 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.21e-06 | 10 | 183 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.21e-06 | 10 | 183 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.21e-06 | 10 | 183 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.21e-06 | 10 | 183 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 1.21e-06 | 22 | 183 | 5 | GO:1902644 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.88e-06 | 11 | 183 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.88e-06 | 11 | 183 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 2.94e-06 | 26 | 183 | 5 | GO:0010566 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 5.60e-06 | 14 | 183 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 5.60e-06 | 14 | 183 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 7.58e-06 | 15 | 183 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 1.00e-05 | 16 | 183 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 1.00e-05 | 16 | 183 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | synapse organization | DOCK1 RELN CTTNBP2 SPTBN2 L1CAM DOCK10 NBEA CHD4 PLXND1 APOE YWHAZ NEFH SLIT2 SRPX2 NF1 HMCN2 SRGAP3 ADGRL2 SEMA3E | 1.17e-05 | 685 | 183 | 19 | GO:0050808 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.18e-05 | 34 | 183 | 5 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 1.36e-05 | 35 | 183 | 5 | GO:0120255 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 1.66e-05 | 18 | 183 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | cell junction organization | DOCK1 RELN CTTNBP2 ANK2 SPTBN2 L1CAM DOCK10 NBEA CHD4 ITGA2 PLXND1 APOE YWHAZ NEFH SLIT2 CCM2 SRPX2 NF1 HMCN2 SRGAP3 HRG ADGRL2 SEMA3E | 1.84e-05 | 974 | 183 | 23 | GO:0034330 |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 2.06e-05 | 38 | 183 | 5 | GO:0048384 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.19e-05 | 21 | 183 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 3.19e-05 | 21 | 183 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 3.19e-05 | 21 | 183 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 3.19e-05 | 21 | 183 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 3.87e-05 | 22 | 183 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 3.87e-05 | 22 | 183 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | parturition | 3.87e-05 | 22 | 183 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | DOCK1 RELN CTTNBP2 L1CAM DOCK10 CHD4 APOE YWHAZ SLIT2 SRPX2 NF1 SRGAP3 ADGRL2 | 4.42e-05 | 387 | 183 | 13 | GO:0050807 |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 4.49e-05 | 106 | 183 | 7 | GO:0050810 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 4.65e-05 | 23 | 183 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 4.65e-05 | 23 | 183 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | DOCK1 RELN CTTNBP2 L1CAM DOCK10 CHD4 APOE YWHAZ SLIT2 SRPX2 NF1 SRGAP3 ADGRL2 | 5.45e-05 | 395 | 183 | 13 | GO:0050803 |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 5.90e-05 | 47 | 183 | 5 | GO:0046164 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | DOCK1 FNDC3B EPPK1 NCKAP1 SEMA5A ITGA2 PLXND1 APOE SLIT2 PTP4A3 SRPX2 NF1 HRG EMP2 NOS3 SEMA3E | 5.92e-05 | 577 | 183 | 16 | GO:0001667 |
| GeneOntologyBiologicalProcess | mitochondrial NAD transmembrane transport | 7.83e-05 | 2 | 183 | 2 | GO:1990549 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOCK1 RELN ARHGAP15 NCKAP1 DOCK10 ARHGAP9 SIAH2 APOE RAB6C FARP2 SLIT2 NF1 SRGAP3 ARHGAP12 TNK2 | 9.54e-05 | 538 | 183 | 15 | GO:0007264 |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 9.65e-05 | 52 | 183 | 5 | GO:0071526 | |
| GeneOntologyBiologicalProcess | synapse assembly | DOCK1 RELN SPTBN2 L1CAM DOCK10 CHD4 PLXND1 SLIT2 SRPX2 SRGAP3 ADGRL2 | 1.01e-04 | 308 | 183 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.04e-04 | 28 | 183 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 1.20e-04 | 29 | 183 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.20e-04 | 29 | 183 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | DOCK1 EPPK1 SEMA5A ITGA2 PLXND1 APOE SLIT2 PTP4A3 SRPX2 NF1 HRG EMP2 NOS3 | 1.34e-04 | 432 | 183 | 13 | GO:0010631 |
| GeneOntologyBiologicalProcess | epithelium migration | DOCK1 EPPK1 SEMA5A ITGA2 PLXND1 APOE SLIT2 PTP4A3 SRPX2 NF1 HRG EMP2 NOS3 | 1.43e-04 | 435 | 183 | 13 | GO:0090132 |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 1.50e-04 | 57 | 183 | 5 | GO:0042181 | |
| GeneOntologyBiologicalProcess | diencephalon development | 1.51e-04 | 90 | 183 | 6 | GO:0021536 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 1.60e-04 | 91 | 183 | 6 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 1.63e-04 | 58 | 183 | 5 | GO:0032350 | |
| GeneOntologyBiologicalProcess | tissue migration | DOCK1 EPPK1 SEMA5A ITGA2 PLXND1 APOE SLIT2 PTP4A3 SRPX2 NF1 HRG EMP2 NOS3 | 1.64e-04 | 441 | 183 | 13 | GO:0090130 |
| GeneOntologyBiologicalProcess | neuron recognition | 1.77e-04 | 59 | 183 | 5 | GO:0008038 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 1.78e-04 | 32 | 183 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 2.01e-04 | 33 | 183 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 2.06e-04 | 135 | 183 | 7 | GO:0019218 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor catabolic process | 2.33e-04 | 3 | 183 | 2 | GO:0032805 | |
| GeneOntologyBiologicalProcess | synaptic target recognition | 2.33e-04 | 3 | 183 | 2 | GO:0008039 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 2.33e-04 | 3 | 183 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell migration | 2.63e-04 | 344 | 183 | 11 | GO:0010632 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 2.83e-04 | 36 | 183 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 2.83e-04 | 36 | 183 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 4.27e-04 | 40 | 183 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 4.57e-04 | 202 | 183 | 8 | GO:0051963 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid efflux | 4.64e-04 | 4 | 183 | 2 | GO:1902994 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid efflux | 4.64e-04 | 4 | 183 | 2 | GO:1902995 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 4.64e-04 | 4 | 183 | 2 | GO:0098910 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.80e-04 | 73 | 183 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 5.11e-04 | 74 | 183 | 5 | GO:2000351 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 5.16e-04 | 42 | 183 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | ANK2 NCKAP1 SPTBN2 SEMA5A RICTOR RYR2 SLIT2 RHPN2 RHPN2P1 HRG GRHL3 FCHSD1 | 5.62e-04 | 438 | 183 | 12 | GO:0032970 |
| GeneOntologyBiologicalProcess | cell junction assembly | DOCK1 RELN ANK2 SPTBN2 L1CAM DOCK10 CHD4 ITGA2 PLXND1 SLIT2 SRPX2 SRGAP3 HRG ADGRL2 | 5.76e-04 | 569 | 183 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 6.72e-04 | 45 | 183 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 6.90e-04 | 79 | 183 | 5 | GO:0072577 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 7.31e-04 | 217 | 183 | 8 | GO:0051897 | |
| GeneOntologyBiologicalProcess | regulation of AV node cell action potential | 7.69e-04 | 5 | 183 | 2 | GO:0098904 | |
| GeneOntologyBiologicalProcess | NAD transmembrane transport | 7.69e-04 | 5 | 183 | 2 | GO:0035352 | |
| GeneOntologyBiologicalProcess | endothelial cell migration | 7.74e-04 | 331 | 183 | 10 | GO:0043542 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | EPPK1 KRT15 NCKAP1 SPTBN2 SIAH1 SEMA5A SIAH2 RICTOR APOE AXIN1 NEFH SLIT2 NF1 RHPN2 ARHGAP12 CST3 RHPN2P1 EMP2 FCHSD1 | 8.87e-04 | 957 | 183 | 19 | GO:0097435 |
| GeneOntologyBiologicalProcess | axon guidance | 1.04e-03 | 285 | 183 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.06e-03 | 286 | 183 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 1.12e-03 | 88 | 183 | 5 | GO:0071277 | |
| GeneOntologyBiologicalProcess | NAD transport | 1.15e-03 | 6 | 183 | 2 | GO:0043132 | |
| GeneOntologyBiologicalProcess | NMDA glutamate receptor clustering | 1.15e-03 | 6 | 183 | 2 | GO:0097114 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 1.18e-03 | 89 | 183 | 5 | GO:2000379 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CTTNBP2 ANK2 NCKAP1 SPTBN2 SEMA5A RICTOR RYR2 FARP2 SLIT2 NF1 RHPN2 MYH14 ARHGAP12 RHPN2P1 HRG EMP2 GRHL3 FCHSD1 | 1.30e-03 | 912 | 183 | 18 | GO:0030029 |
| GeneOntologyCellularComponent | glutamatergic synapse | DOCK1 CTTNBP2 VPS26B SPTBN2 L1CAM ANKS1B DOCK10 NCAM1 NBEA CHD4 GRIK4 PLXND1 APOE PDE10A YWHAZ NCDN NF1 SRGAP3 ADGRL2 | 8.45e-05 | 817 | 180 | 19 | GO:0098978 |
| GeneOntologyCellularComponent | cell body | PITPNM2 RELN SPTBN2 L1CAM GLRA3 NCAM1 SIAH2 GRIK4 PLXND1 APOE PDE10A NCDN NEFH SLIT2 HMCN2 CST3 MTNR1A TNK2 WDFY3 FCHSD1 | 1.55e-04 | 929 | 180 | 20 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | RELN SPTBN2 L1CAM GLRA3 NCAM1 SIAH2 GRIK4 APOE PDE10A NCDN NEFH SLIT2 HMCN2 CST3 MTNR1A TNK2 WDFY3 FCHSD1 | 3.30e-04 | 835 | 180 | 18 | GO:0043025 |
| GeneOntologyCellularComponent | somatodendritic compartment | RELN CTTNBP2 SPTBN2 L1CAM GLRA3 ANKS1B DOCK10 NCAM1 SIAH2 GRIK4 APOE LMTK3 PDE10A NCDN NEFH SLIT2 NF1 HMCN2 CST3 MTNR1A TNK2 WDFY3 FCHSD1 | 3.72e-04 | 1228 | 180 | 23 | GO:0036477 |
| MousePheno | increased circulating progesterone level | 2.99e-07 | 15 | 144 | 5 | MP:0005186 | |
| MousePheno | parturition failure | 2.16e-06 | 10 | 144 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 3.37e-06 | 11 | 144 | 4 | MP:0010050 | |
| MousePheno | decreased vocalization | 7.18e-06 | 46 | 144 | 6 | MP:0020351 | |
| MousePheno | increased oligodendrocyte number | 7.18e-06 | 13 | 144 | 4 | MP:0010160 | |
| MousePheno | ectopic neuron | 9.25e-06 | 48 | 144 | 6 | MP:0011723 | |
| MousePheno | prolonged diestrus | 1.25e-05 | 30 | 144 | 5 | MP:0009011 | |
| MousePheno | long stride length | 1.35e-05 | 15 | 144 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 1.35e-05 | 15 | 144 | 4 | MP:0002293 | |
| MousePheno | abnormal diestrus | 2.74e-05 | 35 | 144 | 5 | MP:0009010 | |
| MousePheno | abnormal social/conspecific interaction behavior | RELN CTTNBP2 ANK2 L1CAM BBS1 NBEA AKR1C4 APOE LMTK3 PDE10A AKR1C1 AKR1C2 SRPX2 SRGAP3 AKR1C3 | 2.91e-05 | 421 | 144 | 15 | MP:0002557 |
| MousePheno | abnormal gestational length | 2.95e-05 | 18 | 144 | 4 | MP:0002292 | |
| MousePheno | abnormal vocalization | CTTNBP2 ANK2 INTS7 NOXA1 AKR1C4 INO80 AKR1C1 AKR1C2 ZC3H7A SRPX2 AKR1C3 | 3.40e-05 | 237 | 144 | 11 | MP:0001529 |
| MousePheno | enhanced coordination | 4.13e-05 | 38 | 144 | 5 | MP:0003858 | |
| MousePheno | dysmyelination | 4.60e-05 | 20 | 144 | 4 | MP:0013438 | |
| MousePheno | prolonged estrous cycle | 4.70e-05 | 39 | 144 | 5 | MP:0009006 | |
| MousePheno | decreased oligodendrocyte number | 1.15e-04 | 25 | 144 | 4 | MP:0009808 | |
| MousePheno | abnormal circulating progesterone level | 1.58e-04 | 50 | 144 | 5 | MP:0005184 | |
| MousePheno | abnormal heart septum morphology | DOCK1 CHD4 PLXND1 RYR1 RYR2 SLIT2 NF1 DHX35 WDFY3 ADGRL2 NOS3 KDM1A DNAH11 | 1.87e-04 | 388 | 144 | 13 | MP:0006113 |
| MousePheno | abnormal neurite morphology | SH3TC2 ABCA2 ANK2 ACP2 SPTBN2 L1CAM BBS1 BCL2L2 APOE YWHAZ NEFH SLIT2 KIDINS220 SRGAP3 | 1.89e-04 | 442 | 144 | 14 | MP:0008415 |
| MousePheno | increased stereotypic behavior | 2.09e-04 | 53 | 144 | 5 | MP:0001409 | |
| MousePheno | abnormal interventricular septum morphology | DOCK1 CHD4 PLXND1 RYR2 SLIT2 NF1 DHX35 WDFY3 ADGRL2 NOS3 KDM1A DNAH11 | 2.18e-04 | 342 | 144 | 12 | MP:0000281 |
| MousePheno | abnormal progesterone level | 2.28e-04 | 54 | 144 | 5 | MP:0011384 | |
| MousePheno | abnormal tectorial membrane morphology | 3.10e-04 | 32 | 144 | 4 | MP:0003149 | |
| MousePheno | renal glomerulus lipidosis | 3.14e-04 | 3 | 144 | 2 | MP:0011561 | |
| MousePheno | abnormal parturition | 3.50e-04 | 33 | 144 | 4 | MP:0002907 | |
| MousePheno | ventricular septal defect | 3.71e-04 | 261 | 144 | 10 | MP:0010402 | |
| MousePheno | stereotypic behavior | SLC26A4 ANKS1B AKR1C4 AKR1C1 AKR1C2 AXIN1 ATP6V0A4 AKR1C3 GRHL3 | 3.73e-04 | 214 | 144 | 9 | MP:0001408 |
| Domain | - | 3.07e-07 | 16 | 179 | 5 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 4.31e-07 | 17 | 179 | 5 | IPR023210 | |
| Domain | Aldo_ket_red | 4.31e-07 | 17 | 179 | 5 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 4.31e-07 | 17 | 179 | 5 | IPR001395 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.64e-06 | 10 | 179 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.64e-06 | 10 | 179 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.64e-06 | 10 | 179 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 1.64e-06 | 10 | 179 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.64e-06 | 10 | 179 | 4 | IPR020471 | |
| Domain | Rho_GTPase_act | 3.44e-06 | 4 | 179 | 3 | IPR015767 | |
| Domain | DUF4704 | 8.54e-06 | 5 | 179 | 3 | IPR031570 | |
| Domain | DUF4704 | 8.54e-06 | 5 | 179 | 3 | PF15787 | |
| Domain | PH_BEACH | 1.70e-05 | 6 | 179 | 3 | PF14844 | |
| Domain | SH3_1 | 2.96e-05 | 164 | 179 | 9 | PF00018 | |
| Domain | SH3 | DOCK1 SH3TC2 AHI1 NOXA1 ARHGAP9 SRGAP3 ZDHHC6 ARHGAP12 TNK2 FCHSD1 | 4.58e-05 | 216 | 179 | 10 | SM00326 |
| Domain | PH-BEACH_dom | 4.68e-05 | 8 | 179 | 3 | IPR023362 | |
| Domain | - | 4.68e-05 | 8 | 179 | 3 | 2.30.29.40 | |
| Domain | PH_BEACH | 4.68e-05 | 8 | 179 | 3 | PS51783 | |
| Domain | SH3_domain | DOCK1 SH3TC2 AHI1 NOXA1 ARHGAP9 SRGAP3 ZDHHC6 ARHGAP12 TNK2 FCHSD1 | 5.35e-05 | 220 | 179 | 10 | IPR001452 |
| Domain | BEACH | 6.97e-05 | 9 | 179 | 3 | PS50197 | |
| Domain | Beach | 6.97e-05 | 9 | 179 | 3 | PF02138 | |
| Domain | - | 6.97e-05 | 9 | 179 | 3 | 1.10.1540.10 | |
| Domain | Beach | 6.97e-05 | 9 | 179 | 3 | SM01026 | |
| Domain | BEACH_dom | 6.97e-05 | 9 | 179 | 3 | IPR000409 | |
| Domain | DUF1088 | 9.13e-05 | 2 | 179 | 2 | IPR010508 | |
| Domain | DUF1088 | 9.13e-05 | 2 | 179 | 2 | PF06469 | |
| Domain | - | ANKRD31 CTTNBP2 ANK2 ANKS1B YTHDC2 RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 1.44e-04 | 248 | 179 | 10 | 1.25.40.20 |
| Domain | ANK | ANKRD31 CTTNBP2 ANK2 ANKS1B YTHDC2 RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 1.59e-04 | 251 | 179 | 10 | SM00248 |
| Domain | ANK_REPEAT | ANKRD31 CTTNBP2 ANK2 ANKS1B YTHDC2 RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 1.70e-04 | 253 | 179 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD31 CTTNBP2 ANK2 ANKS1B YTHDC2 RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 1.75e-04 | 254 | 179 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD31 CTTNBP2 ANK2 ANKS1B YTHDC2 RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 1.75e-04 | 254 | 179 | 10 | PS50297 |
| Domain | Rho_GTPase_activation_prot | 2.02e-04 | 88 | 179 | 6 | IPR008936 | |
| Domain | Ankyrin_rpt | ANKRD31 CTTNBP2 ANK2 ANKS1B YTHDC2 RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 2.25e-04 | 262 | 179 | 10 | IPR002110 |
| Domain | Ank_2 | ANKRD31 CTTNBP2 ANK2 ANKS1B RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 2.35e-04 | 215 | 179 | 9 | PF12796 |
| Domain | SH3 | 2.43e-04 | 216 | 179 | 9 | PS50002 | |
| Domain | Ryanodine_rcpt | 2.72e-04 | 3 | 179 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 2.72e-04 | 3 | 179 | 2 | IPR009460 | |
| Domain | Elf-1_N | 2.72e-04 | 3 | 179 | 2 | PF12310 | |
| Domain | 7-in-absentia-prot_TRAF-dom | 2.72e-04 | 3 | 179 | 2 | IPR018121 | |
| Domain | RyR | 2.72e-04 | 3 | 179 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 2.72e-04 | 3 | 179 | 2 | PF06459 | |
| Domain | TF_Elf_N | 2.72e-04 | 3 | 179 | 2 | IPR022084 | |
| Domain | Sina | 2.72e-04 | 3 | 179 | 2 | PF03145 | |
| Domain | Ryan_recept | 2.72e-04 | 3 | 179 | 2 | IPR013333 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.92e-04 | 14 | 179 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.92e-04 | 14 | 179 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.92e-04 | 14 | 179 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.92e-04 | 14 | 179 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.92e-04 | 14 | 179 | 3 | IPR011704 | |
| Domain | - | 2.92e-04 | 14 | 179 | 3 | 2.60.210.10 | |
| Domain | MT | 2.92e-04 | 14 | 179 | 3 | PF12777 | |
| Domain | AAA_8 | 2.92e-04 | 14 | 179 | 3 | PF12780 | |
| Domain | AAA_5 | 2.92e-04 | 14 | 179 | 3 | PF07728 | |
| Domain | DHC_fam | 3.62e-04 | 15 | 179 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.62e-04 | 15 | 179 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.62e-04 | 15 | 179 | 3 | IPR004273 | |
| Domain | Ank | ANKRD31 CTTNBP2 ANK2 ANKS1B RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 3.62e-04 | 228 | 179 | 9 | PF00023 |
| Domain | DUF1605 | 5.33e-04 | 17 | 179 | 3 | IPR011709 | |
| Domain | OB_NTP_bind | 5.33e-04 | 17 | 179 | 3 | PF07717 | |
| Domain | SINA-like | 5.41e-04 | 4 | 179 | 2 | IPR004162 | |
| Domain | Znf_SIAH | 5.41e-04 | 4 | 179 | 2 | IPR013010 | |
| Domain | HA2 | 6.35e-04 | 18 | 179 | 3 | SM00847 | |
| Domain | HA2 | 6.35e-04 | 18 | 179 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 6.35e-04 | 18 | 179 | 3 | IPR007502 | |
| Domain | ZF_SIAH | 8.96e-04 | 5 | 179 | 2 | PS51081 | |
| Domain | TPR_REGION | 1.08e-03 | 165 | 179 | 7 | PS50293 | |
| Domain | TPR | 1.08e-03 | 165 | 179 | 7 | PS50005 | |
| Domain | ARM-like | 1.21e-03 | 270 | 179 | 9 | IPR011989 | |
| Domain | RIH_assoc-dom | 1.34e-03 | 6 | 179 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.34e-03 | 6 | 179 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.34e-03 | 6 | 179 | 2 | PF08454 | |
| Domain | RIH_dom | 1.34e-03 | 6 | 179 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.34e-03 | 6 | 179 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.34e-03 | 6 | 179 | 2 | IPR015925 | |
| Domain | - | 1.34e-03 | 6 | 179 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.34e-03 | 6 | 179 | 2 | PF01365 | |
| Domain | TRAF-like | 1.51e-03 | 24 | 179 | 3 | IPR008974 | |
| Domain | ARM-type_fold | 1.64e-03 | 339 | 179 | 10 | IPR016024 | |
| Domain | DHC_N1 | 2.46e-03 | 8 | 179 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.46e-03 | 8 | 179 | 2 | IPR013594 | |
| Domain | AAA | 2.67e-03 | 144 | 179 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 2.67e-03 | 144 | 179 | 6 | IPR003593 | |
| Domain | PH_dom-like | ARHGAP15 SPTBN2 ANKS1B DOCK10 ARHGAP9 NBEA FARP2 CCM2 ARHGAP12 WDFY3 LRBA | 2.76e-03 | 426 | 179 | 11 | IPR011993 |
| Domain | RhoGAP | 2.95e-03 | 62 | 179 | 4 | SM00324 | |
| Domain | RhoGAP | 3.13e-03 | 63 | 179 | 4 | PF00620 | |
| Domain | Semap_dom | 3.19e-03 | 31 | 179 | 3 | IPR001627 | |
| Domain | SEMA | 3.19e-03 | 31 | 179 | 3 | PS51004 | |
| Domain | Sema | 3.19e-03 | 31 | 179 | 3 | SM00630 | |
| Domain | Sema | 3.19e-03 | 31 | 179 | 3 | PF01403 | |
| Domain | RhoGAP_dom | 3.31e-03 | 64 | 179 | 4 | IPR000198 | |
| Domain | RHOGAP | 3.31e-03 | 64 | 179 | 4 | PS50238 | |
| Domain | - | 3.31e-03 | 64 | 179 | 4 | 1.10.555.10 | |
| Domain | Helicase_C | 3.85e-03 | 108 | 179 | 5 | IPR001650 | |
| Domain | MIR | 3.91e-03 | 10 | 179 | 2 | PF02815 | |
| Domain | MIR_motif | 3.91e-03 | 10 | 179 | 2 | IPR016093 | |
| Domain | MIR | 3.91e-03 | 10 | 179 | 2 | PS50919 | |
| Domain | MIR | 3.91e-03 | 10 | 179 | 2 | SM00472 | |
| Domain | HELICASE_CTER | 4.00e-03 | 109 | 179 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.00e-03 | 109 | 179 | 5 | PS51192 | |
| Domain | DEXDc | 4.00e-03 | 109 | 179 | 5 | SM00487 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.04e-06 | 9 | 137 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.04e-06 | 9 | 137 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.67e-06 | 11 | 137 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 5.70e-06 | 13 | 137 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 5.70e-06 | 13 | 137 | 4 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 7.92e-06 | 14 | 137 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 7.92e-06 | 14 | 137 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 7.92e-06 | 14 | 137 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 7.92e-06 | 14 | 137 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.07e-05 | 15 | 137 | 4 | MM14870 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | DOCK1 ARHGAP15 NCKAP1 NOXA1 DOCK10 ARHGAP9 FARP2 SRGAP3 ARHGAP12 | 5.24e-05 | 175 | 137 | 9 | MM15599 |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 6.55e-05 | 23 | 137 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 6.55e-05 | 23 | 137 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 6.55e-05 | 23 | 137 | 4 | MM14741 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 7.20e-05 | 45 | 137 | 5 | MM15344 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | DOCK1 ARHGAP15 NCKAP1 NOXA1 DOCK10 ARHGAP9 FARP2 SRGAP3 ARHGAP12 | 7.72e-05 | 184 | 137 | 9 | M41809 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | DOCK1 RELN ANK2 SPTBN2 L1CAM NCAM1 SIAH1 SEMA5A SIAH2 ITGA2 PLXND1 FARP2 SLIT2 MYH14 SRGAP3 SEMA3E | 1.45e-04 | 575 | 137 | 16 | M29853 |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.46e-04 | 28 | 137 | 4 | MM15188 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.81e-04 | 33 | 137 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 2.81e-04 | 33 | 137 | 4 | MM14737 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 3.02e-04 | 14 | 137 | 3 | MM15047 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.88e-04 | 64 | 137 | 5 | M7923 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 5.16e-04 | 189 | 137 | 8 | MM14772 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 7.76e-04 | 19 | 137 | 3 | M10959 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 8.57e-04 | 44 | 137 | 4 | M499 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 8.57e-04 | 44 | 137 | 4 | M875 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 9.34e-04 | 45 | 137 | 4 | MM14751 | |
| Pubmed | 8.17e-11 | 7 | 184 | 5 | 26160177 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 10393440 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 7.58e-10 | 4 | 184 | 4 | 31479646 | |
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 10702227 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 17442338 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 28329705 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 16511129 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 15222881 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 10526179 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 21521174 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 8274401 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 7.58e-10 | 4 | 184 | 4 | 34590152 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 7.58e-10 | 4 | 184 | 4 | 10500239 | |
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 7.58e-10 | 4 | 184 | 4 | 14967952 | |
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 7.58e-10 | 4 | 184 | 4 | 15193432 | |
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 16191478 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 15577209 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 7.58e-10 | 4 | 184 | 4 | 29764944 | |
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 17888864 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 19237748 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 28259989 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 7789999 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 7.58e-10 | 4 | 184 | 4 | 16508162 | |
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 17629694 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 16018803 | ||
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 7.58e-10 | 4 | 184 | 4 | 18667791 | |
| Pubmed | 3.78e-09 | 5 | 184 | 4 | 7737980 | ||
| Pubmed | 3.78e-09 | 5 | 184 | 4 | 38788959 | ||
| Pubmed | 3.78e-09 | 5 | 184 | 4 | 18003893 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 3.78e-09 | 5 | 184 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 3.78e-09 | 5 | 184 | 4 | 16984997 | |
| Pubmed | 3.78e-09 | 5 | 184 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 3.78e-09 | 5 | 184 | 4 | 17064890 | |
| Pubmed | 3.78e-09 | 5 | 184 | 4 | 10672042 | ||
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 6.91e-09 | 28 | 184 | 6 | 29212953 | |
| Pubmed | DMXL2 CTTNBP2 ANK2 NCKAP1 SPTBN2 ANKS1B NCAM1 NBEA CHD4 LMTK3 YWHAZ NCDN RCOR2 NEFH RCOR1 NF1 SRGAP3 ELAVL3 WDFY3 CNOT1 KDM1A SEC23A | 9.88e-09 | 963 | 184 | 22 | 28671696 | |
| Pubmed | PITPNM2 DMXL2 CTTNBP2 ANK2 NCKAP1 SPTBN2 L1CAM COX6C ANKS1B NCAM1 YTHDC2 NBEA ITGA2 APOE YWHAZ NCDN NEFH KIDINS220 NF1 MYH14 SRGAP3 HRG ELAVL3 SLC25A11 CNOT1 SEC23A DNAH11 | 1.05e-08 | 1431 | 184 | 27 | 37142655 | |
| Pubmed | 1.13e-08 | 6 | 184 | 4 | 19273550 | ||
| Pubmed | 1.13e-08 | 6 | 184 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 1.13e-08 | 6 | 184 | 4 | 26748576 | |
| Pubmed | 1.13e-08 | 6 | 184 | 4 | 17122075 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 1.13e-08 | 6 | 184 | 4 | 29107092 | |
| Pubmed | 1.13e-08 | 6 | 184 | 4 | 15860270 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 1.13e-08 | 6 | 184 | 4 | 17255200 | |
| Pubmed | 2.62e-08 | 7 | 184 | 4 | 33127481 | ||
| Pubmed | 2.62e-08 | 7 | 184 | 4 | 12562828 | ||
| Pubmed | 2.62e-08 | 7 | 184 | 4 | 22529366 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 2.62e-08 | 7 | 184 | 4 | 34843575 | |
| Pubmed | 2.62e-08 | 7 | 184 | 4 | 16337335 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | PITPNM2 DMXL2 ANK2 NCKAP1 SPTBN2 ANKS1B NCAM1 NBEA YWHAZ NCDN NF1 SRGAP3 | 3.89e-08 | 281 | 184 | 12 | 28706196 |
| Pubmed | 5.22e-08 | 8 | 184 | 4 | 20837989 | ||
| Pubmed | 5.22e-08 | 8 | 184 | 4 | 33584538 | ||
| Pubmed | 5.22e-08 | 8 | 184 | 4 | 9224647 | ||
| Pubmed | 9.05e-08 | 42 | 184 | 6 | 15146195 | ||
| Pubmed | 9.36e-08 | 9 | 184 | 4 | 33348080 | ||
| Pubmed | DMXL2 CTTNBP2 ANK2 NCKAP1 SPTBN2 ANKS1B NCAM1 NBEA YWHAZ NCDN NEFH | 1.12e-07 | 251 | 184 | 11 | 27507650 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 19320734 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 21876670 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 21232532 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 1.46e-07 | 3 | 184 | 3 | 31780644 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 13678667 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 7626489 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 1.55e-07 | 10 | 184 | 4 | 36313771 | |
| Pubmed | DMXL2 RELN ABCA2 VSNL1 ANK2 B4GAT1 SPTBN2 RTL10 ANKS1B TTC27 SIAH1 NBEA CHD4 APOE CFAP298 YWHAZ UBA7 MYH14 AKR1C3 DHX35 WDFY3 LRBA KLHL4 | 3.63e-07 | 1285 | 184 | 23 | 35914814 | |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 3.63e-07 | 12 | 184 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 3.63e-07 | 12 | 184 | 4 | 28893949 | |
| Pubmed | 3.63e-07 | 12 | 184 | 4 | 25774556 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 11682476 | ||
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 24580729 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 5.22e-07 | 13 | 184 | 4 | 15117747 | |
| Pubmed | 5.22e-07 | 13 | 184 | 4 | 17062636 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 23592795 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 24632616 | ||
| Pubmed | 7.28e-07 | 14 | 184 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 7.28e-07 | 14 | 184 | 4 | 34400844 | |
| Pubmed | CoREST/LSD1 control the development of pyramidal cortical neurons. | 1.45e-06 | 5 | 184 | 3 | 21878487 | |
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 15212687 | ||
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 32594343 | ||
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 28546513 | ||
| Pubmed | 1.45e-06 | 5 | 184 | 3 | 23430613 | ||
| Pubmed | 1.49e-06 | 37 | 184 | 5 | 21362171 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | PITPNM2 INTS7 YTHDC2 ACAD10 INO80 LMTK3 YWHAZ SLIT2 CCM2 NF1 ARHGAP12 ELAVL3 SLC25A11 | 1.70e-06 | 475 | 184 | 13 | 31040226 |
| Pubmed | 1.71e-06 | 17 | 184 | 4 | 32243503 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PITPNM2 ABCA2 EPPK1 L1CAM SIAH2 PIGG PLXND1 INO80 LARS2 ABCA7 RYR1 CLCN7 KCNG1 TNK2 TNFAIP2 WDFY3 UBE3C LRBA ABTB2 HOXB13 | 1.88e-06 | 1105 | 184 | 20 | 35748872 |
| Pubmed | LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. | 2.19e-06 | 18 | 184 | 4 | 19497860 | |
| Pubmed | FNDC3B DMXL2 NOL6 DOCK10 RICTOR YTHDC2 FHIP2A MAP3K6 NCDN FAM111B FARP2 RHPN2 SLC25A11 TNFAIP2 SEMA3E | 2.20e-06 | 650 | 184 | 15 | 38777146 | |
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 2.76e-06 | 19 | 184 | 4 | 17599069 | |
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 27112428 | ||
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 23208506 | ||
| Pubmed | Antagonistic actions of Rcor proteins regulate LSD1 activity and cellular differentiation. | 2.88e-06 | 6 | 184 | 3 | 24843136 | |
| Pubmed | Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. | 2.88e-06 | 6 | 184 | 3 | 23576758 | |
| Pubmed | 3.44e-06 | 20 | 184 | 4 | 23636947 | ||
| Pubmed | 3.44e-06 | 20 | 184 | 4 | 24135228 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | DOCK1 EPPK1 CTTNBP2 ARHGAP9 PLXND1 MYH14 MRPS2 SNRPD3 KCNAB3 | 4.94e-06 | 235 | 184 | 9 | 30258100 |
| Pubmed | 5.02e-06 | 7 | 184 | 3 | 19846565 | ||
| Interaction | AKR1C4 interactions | 4.38e-07 | 8 | 182 | 4 | int:AKR1C4 | |
| Cytoband | 10p15-p14 | 1.26e-06 | 6 | 184 | 3 | 10p15-p14 | |
| Cytoband | 13q13 | 1.59e-04 | 5 | 184 | 2 | 13q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 4.88e-04 | 90 | 184 | 4 | chr10p15 | |
| GeneFamily | Aldo-keto reductases | 5.24e-08 | 15 | 131 | 5 | 399 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.02e-05 | 9 | 131 | 3 | 1230 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD31 CTTNBP2 ANK2 ANKS1B RNASEL KIDINS220 ASB5 ASB7 ABTB2 | 6.81e-05 | 242 | 131 | 9 | 403 |
| GeneFamily | Protein tyrosine phosphatases type IVA | 1.56e-04 | 3 | 131 | 2 | 899 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.56e-04 | 3 | 131 | 2 | 287 | |
| GeneFamily | Dyneins, axonemal | 2.35e-04 | 17 | 131 | 3 | 536 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.68e-04 | 50 | 131 | 4 | 721 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.75e-08 | 25 | 184 | 6 | MM480 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | ABCA2 NCAM1 NBEA CDHR5 AKR1C4 AKR1C1 AKR1C2 SLIT2 RCOR1 AKR1C3 | 3.64e-06 | 219 | 184 | 10 | MM1237 |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 5.21e-06 | 17 | 184 | 4 | MM826 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 8.03e-06 | 143 | 184 | 8 | MM989 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 2.24e-05 | 24 | 184 | 4 | MM766 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN | 2.31e-05 | 81 | 184 | 6 | M34025 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CADM3 RELN VSNL1 ANK2 L1CAM ANKS1B NCAM1 RICTOR NBEA AKR1C1 AKR1C2 NCDN PXK RCOR2 RYR2 FSIP2 SRGAP3 ELAVL3 TNK2 C2CD6 SEMA3E | 3.54e-05 | 1106 | 184 | 21 | M39071 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 3.56e-05 | 228 | 184 | 9 | MM1014 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 5.54e-05 | 187 | 184 | 8 | M6807 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 5.58e-05 | 30 | 184 | 4 | MM853 | |
| Coexpression | EIF4E_DN | 7.61e-05 | 100 | 184 | 6 | M2790 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | RELN ANK2 SLC26A4 SPTBN2 AKR1C4 H6PD AKR1C1 AKR1C2 AKR1C3 ERICH6 | 8.71e-05 | 317 | 184 | 10 | MM956 |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN | 8.87e-05 | 200 | 184 | 8 | M3571 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP | 8.87e-05 | 200 | 184 | 8 | M7516 | |
| Coexpression | GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 8.87e-05 | 200 | 184 | 8 | M6563 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 1.16e-04 | 36 | 184 | 4 | MM3660 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | VSNL1 ANK2 L1CAM ANKS1B NCAM1 NBEA LMTK3 AKR1C1 NCDN RCOR2 RYR2 ELAVL3 | 1.18e-04 | 465 | 184 | 12 | M39066 |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 1.26e-04 | 69 | 184 | 5 | MM621 | |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_UP | 1.29e-04 | 110 | 184 | 6 | M1696 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 1.30e-04 | 37 | 184 | 4 | MM630 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-07 | 199 | 183 | 9 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-07 | 176 | 183 | 8 | 3c78dee7e1111a579fde6d401b9ecb4d5b8e782f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-07 | 176 | 183 | 8 | bfea433544c6d6b8ad55e50ca94c5574460c2e0b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 185 | 183 | 8 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-06 | 190 | 183 | 8 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 191 | 183 | 8 | feec8617678b778475747ad406c80231e07fd6f7 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.63e-06 | 197 | 183 | 8 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-06 | 197 | 183 | 8 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-06 | 197 | 183 | 8 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 199 | 183 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.82e-06 | 200 | 183 | 8 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.82e-06 | 200 | 183 | 8 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.82e-06 | 200 | 183 | 8 | 9b5753726c17dda98d7384a60f26a5eaf4f6c4d6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.82e-06 | 200 | 183 | 8 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-06 | 146 | 183 | 7 | e887e9de895fd453faa703997ef372cc6410fc49 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-06 | 161 | 183 | 7 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 5.12e-06 | 163 | 183 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 164 | 183 | 7 | 8d1d0424943d3e98c8b6399dbf702e0035d0db7b | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 6.50e-06 | 169 | 183 | 7 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 171 | 183 | 7 | 59b9dbaa05b6e5740edc633c9ce1181565550d5b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 171 | 183 | 7 | a5b9dd2b6a54db7962beeb5a9ceb9dacfb613fa7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.47e-06 | 176 | 183 | 7 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | ASK428-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.79e-06 | 177 | 183 | 7 | 66074a288501c136b4e83b883db5f0d8269ee326 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 9.80e-06 | 180 | 183 | 7 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.80e-06 | 180 | 183 | 7 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.13e-05 | 184 | 183 | 7 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-05 | 185 | 183 | 7 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 185 | 183 | 7 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 185 | 183 | 7 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 186 | 183 | 7 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 188 | 183 | 7 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.30e-05 | 188 | 183 | 7 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 189 | 183 | 7 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.37e-05 | 126 | 183 | 6 | 3539a8fdbb52d191f36dce68c38798ad4d2b491a | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.39e-05 | 190 | 183 | 7 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 191 | 183 | 7 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 191 | 183 | 7 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.54e-05 | 193 | 183 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.59e-05 | 194 | 183 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 194 | 183 | 7 | 6165c00ec06a8393f23b0c62f679c143839b03b1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 194 | 183 | 7 | ba529c051f248d29f4222f4bc9801ba233859093 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 194 | 183 | 7 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.59e-05 | 194 | 183 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-05 | 195 | 183 | 7 | 8d286622f86c844d1b06a106ee4a3f813eba05bb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-05 | 195 | 183 | 7 | 359b9d791e26844675c3c60cf69d8ab69c2cf400 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 195 | 183 | 7 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-05 | 195 | 183 | 7 | 4193e58788e90c3d1049ef5cf9800a8c4d8ac354 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-05 | 196 | 183 | 7 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-05 | 196 | 183 | 7 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 1.70e-05 | 196 | 183 | 7 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-05 | 197 | 183 | 7 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 197 | 183 | 7 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-05 | 197 | 183 | 7 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-05 | 197 | 183 | 7 | 58d809ccb8cc4b1e76acf0b8f996cd0e2637290c | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.76e-05 | 197 | 183 | 7 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.76e-05 | 197 | 183 | 7 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-05 | 197 | 183 | 7 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.76e-05 | 197 | 183 | 7 | c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.76e-05 | 197 | 183 | 7 | 2701864e49878c5f323f5133e2c4b0a5a7fff7f5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 197 | 183 | 7 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.76e-05 | 197 | 183 | 7 | 2d92b0483d57541aee382dda80e42cf66e813d6b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.76e-05 | 197 | 183 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.82e-05 | 198 | 183 | 7 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 198 | 183 | 7 | 7b9c7ce5d6b7df8db85943b65da1a2c202a8bb53 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-05 | 198 | 183 | 7 | aa6e7218ee6230902854e66c444b544218b30c0e | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-05 | 199 | 183 | 7 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | proximal-Epithelial-Differentiating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-05 | 199 | 183 | 7 | c607346f60e5997e757e5a31cab412ab3734377b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.88e-05 | 199 | 183 | 7 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.88e-05 | 199 | 183 | 7 | cd581d7330b471431ef427f8a4f5be553f70e068 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-05 | 199 | 183 | 7 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.88e-05 | 199 | 183 | 7 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-05 | 199 | 183 | 7 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 199 | 183 | 7 | b4824d3683a4e3025b8e74a0f1755b331b2a0ba7 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.88e-05 | 199 | 183 | 7 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-05 | 199 | 183 | 7 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | proximal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-05 | 199 | 183 | 7 | 12e07084fc2d5d4c418df564ccc0e132b056e549 | |
| ToppCell | proximal-Epithelial-Differentiating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.88e-05 | 199 | 183 | 7 | 96a89a2578fad9a99c52d2cf9e26e06516a96568 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 1.88e-05 | 199 | 183 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 183 | 7 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | 84e4565d28a02700bf7f6730d1b3a58744ca0aea | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.94e-05 | 200 | 183 | 7 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 1.94e-05 | 200 | 183 | 7 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Cortical_neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | 085060d148158f7d9e938b6c4a3700ccbb3bca15 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | moderate-Epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.94e-05 | 200 | 183 | 7 | 095783c9b75113ae350c2d5fb1195d71b41fa695 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.94e-05 | 200 | 183 | 7 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.94e-05 | 200 | 183 | 7 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-05 | 200 | 183 | 7 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.94e-05 | 200 | 183 | 7 | 0fa3340d945f00ef55c7603476d51bd8346e82c2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 183 | 7 | c7e33057466915d4e2b34f2062b22d9cdffa69dc | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.94e-05 | 200 | 183 | 7 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.92e-05 | 144 | 183 | 6 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 150 | 183 | 6 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 154 | 183 | 6 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 154 | 183 | 6 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 154 | 183 | 6 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.25e-05 | 154 | 183 | 6 | 8a643d91896af9b630a715fb284c1523d01ad1a3 | |
| Drug | cloxazolam | 4.04e-09 | 4 | 183 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 4.04e-09 | 4 | 183 | 4 | ctd:D011278 | |
| Drug | tetralol | 4.04e-09 | 4 | 183 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 4.04e-09 | 4 | 183 | 4 | ctd:C018156 | |
| Drug | octyl gallate | 7.75e-09 | 10 | 183 | 5 | ctd:C016627 | |
| Drug | Hydroxysteroids | 2.01e-08 | 5 | 183 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 2.01e-08 | 5 | 183 | 4 | ctd:C010092 | |
| Drug | Medazepam | 5.98e-08 | 6 | 183 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 2.76e-07 | 8 | 183 | 4 | ctd:D009567 | |
| Drug | Chrysenes | 4.46e-07 | 20 | 183 | 5 | ctd:D002911 | |
| Drug | 4-hydroxybenzoic acid | 4.93e-07 | 9 | 183 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 4.93e-07 | 9 | 183 | 4 | ctd:D004092 | |
| Drug | cyclopentanol | 5.11e-07 | 3 | 183 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 5.11e-07 | 3 | 183 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 5.11e-07 | 3 | 183 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 5.11e-07 | 3 | 183 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 5.11e-07 | 3 | 183 | 3 | ctd:C530610 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.28e-06 | 11 | 183 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.28e-06 | 11 | 183 | 4 | CID000013946 | |
| Drug | Phenolphthalein | 1.90e-06 | 12 | 183 | 4 | ctd:D020113 | |
| Drug | tetrahydrodeoxycorticosterone | 2.03e-06 | 4 | 183 | 3 | ctd:C009413 | |
| Drug | gliquidone | 2.03e-06 | 4 | 183 | 3 | ctd:C010969 | |
| Drug | DBD-H | 2.03e-06 | 4 | 183 | 3 | CID000131382 | |
| Drug | DMBA-3,4-dihydrodiol | 2.73e-06 | 13 | 183 | 4 | CID000050096 | |
| Drug | flunisolide | 2.73e-06 | 13 | 183 | 4 | ctd:C007734 | |
| Drug | AC1L1KF5 | 3.73e-06 | 113 | 183 | 8 | CID000005470 | |
| Drug | 5-alpha-Dihydroprogesterone | 3.80e-06 | 14 | 183 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 3.80e-06 | 14 | 183 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 3.80e-06 | 14 | 183 | 4 | ctd:D008469 | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; PC3; HT_HG-U133A | VSNL1 NCAM1 SEMA5A KCNK12 APOE ITIH2 RNASEL MYH14 SRGAP3 TNFAIP2 | 4.63e-06 | 197 | 183 | 10 | 5054_UP |
| Drug | NSC86000 | 5.05e-06 | 5 | 183 | 3 | CID000257630 | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 5.06e-06 | 199 | 183 | 10 | 6818_UP | |
| Drug | CQ-S | 8.86e-06 | 17 | 183 | 4 | CID000072462 | |
| Drug | AC1L93E5 | 1.00e-05 | 6 | 183 | 3 | CID000412383 | |
| Drug | Estazolam | 1.00e-05 | 6 | 183 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 1.00e-05 | 6 | 183 | 3 | CID000439898 | |
| Drug | Glipizide | 1.00e-05 | 6 | 183 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 1.00e-05 | 6 | 183 | 3 | ctd:C023723 | |
| Drug | oxcarbazepine | 1.42e-05 | 19 | 183 | 4 | ctd:C036006 | |
| Drug | AC1O70V5 | 1.47e-05 | 39 | 183 | 5 | CID006540300 | |
| Drug | 4-hydroxyequilenin-o-quinone | 1.75e-05 | 7 | 183 | 3 | ctd:C117714 | |
| Drug | zomepirac | 1.75e-05 | 7 | 183 | 3 | ctd:C020549 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.77e-05 | 20 | 183 | 4 | ctd:C076588 | |
| Drug | Flunitrazepam | 2.17e-05 | 21 | 183 | 4 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 2.64e-05 | 22 | 183 | 4 | CID000000418 | |
| Drug | 2-cyclohexen-1-ol | 2.78e-05 | 8 | 183 | 3 | CID000013198 | |
| Drug | naphthalene-1,2-dihydrodiol | 2.99e-05 | 45 | 183 | 5 | CID000000362 | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 183 | 9 | 5242_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A | 3.35e-05 | 198 | 183 | 9 | 762_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 183 | 9 | 4695_UP | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 3.35e-05 | 198 | 183 | 9 | 4246_UP | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 183 | 9 | 3532_UP | |
| Drug | Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 183 | 9 | 3551_DN | |
| Drug | Ethionamide [536-33-4]; Down 200; 24uM; PC3; HT_HG-U133A | 3.49e-05 | 199 | 183 | 9 | 4593_DN | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HT_HG-U133A | 3.49e-05 | 199 | 183 | 9 | 6655_DN | |
| Drug | Leflunomide [75706-12-6]; Down 200; 14.8uM; HL60; HT_HG-U133A | 3.49e-05 | 199 | 183 | 9 | 2539_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 3.63e-05 | 200 | 183 | 9 | 6996_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 3.63e-05 | 200 | 183 | 9 | 5782_DN | |
| Drug | Glycyrrhetinic Acid | 3.78e-05 | 24 | 183 | 4 | ctd:D006034 | |
| Drug | Hb H | 4.11e-05 | 48 | 183 | 5 | CID000466959 | |
| Drug | 9,10-phenanthrenequinone | 4.48e-05 | 25 | 183 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 4.48e-05 | 25 | 183 | 4 | ctd:D011280 | |
| Drug | hydride | B4GAT1 SLC26A4 COX6C SHMT1 DUOX2 ARHGAP9 AKR1C4 ITGA2 H6PD AKR1C1 AKR1C2 RYR1 UBA7 ATP6V0A4 AKR1C3 SLC25A11 FAR1 EMP2 NOS3 | 4.59e-05 | 835 | 183 | 19 | CID000000783 |
| Drug | androstane-3,17-dione | 5.53e-05 | 51 | 183 | 5 | CID000000443 | |
| Drug | alpha-methylcinnamic acid | 6.43e-05 | 2 | 183 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 6.43e-05 | 2 | 183 | 2 | DB07768 | |
| Drug | baccharin | 6.43e-05 | 2 | 183 | 2 | ctd:C012764 | |
| Drug | Hexestrol | 7.98e-05 | 55 | 183 | 5 | ctd:D006589 | |
| Drug | coenzyme 1 | SHMT1 DUOX2 SIAH1 AKR1C4 H6PD AKR1C1 AKR1C2 RYR1 RYR2 RCOR1 AKR1C3 SLC25A11 FAR1 EMP2 NOS3 | 1.00e-04 | 596 | 183 | 15 | CID000000925 |
| Drug | phenolphthalein | 1.03e-04 | 58 | 183 | 5 | CID000004764 | |
| Drug | fenamic acid | 1.07e-04 | 12 | 183 | 3 | ctd:C001209 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 1.07e-04 | 31 | 183 | 4 | ctd:C017228 | |
| Drug | picrotoxin | 1.12e-04 | 181 | 183 | 8 | CID000031304 | |
| Drug | 5-ethyluracil | 1.38e-04 | 13 | 183 | 3 | CID000073267 | |
| Drug | 4-formyl-benzoate | 1.38e-04 | 13 | 183 | 3 | CID000012088 | |
| Drug | Apralan | 1.55e-04 | 34 | 183 | 4 | CID000071428 | |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 1.68e-04 | 192 | 183 | 8 | 1173_DN | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; PC3; HT_HG-U133A | 1.68e-04 | 192 | 183 | 8 | 5101_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.74e-04 | 193 | 183 | 8 | 4466_UP | |
| Drug | Dydrogesterone | 1.74e-04 | 14 | 183 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 1.74e-04 | 14 | 183 | 3 | CID000631219 | |
| Drug | 3-hydroxyandrostan-17-one | 1.77e-04 | 102 | 183 | 6 | CID000000225 | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.80e-04 | 194 | 183 | 8 | 2427_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.80e-04 | 194 | 183 | 8 | 4559_DN | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A | 1.80e-04 | 194 | 183 | 8 | 1310_DN | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 1.87e-04 | 195 | 183 | 8 | 834_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A | 1.87e-04 | 195 | 183 | 8 | 7394_UP | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.87e-04 | 195 | 183 | 8 | 7033_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; HL60; HT_HG-U133A | 1.87e-04 | 195 | 183 | 8 | 2460_DN | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.87e-04 | 195 | 183 | 8 | 6662_DN | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.87e-04 | 195 | 183 | 8 | 5819_UP | |
| Drug | cis-diammineplatinum(II | 1.92e-04 | 3 | 183 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.92e-04 | 3 | 183 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 1.92e-04 | 3 | 183 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.92e-04 | 3 | 183 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 1.92e-04 | 3 | 183 | 2 | CID000093551 | |
| Drug | Somnium | 1.92e-04 | 3 | 183 | 2 | CID003082954 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.92e-04 | 3 | 183 | 2 | CID005748312 | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 183 | 8 | 6950_UP | |
| Drug | Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 183 | 8 | 7330_UP | |
| Disease | Neoplasms, Hormone-Dependent | 2.23e-07 | 3 | 180 | 3 | C0027661 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 5.58e-07 | 157 | 180 | 9 | DOID:224 (biomarker_via_orthology) | |
| Disease | Intersex Conditions | 2.21e-06 | 5 | 180 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.21e-06 | 5 | 180 | 3 | C2930619 | |
| Disease | Hermaphroditism | 2.21e-06 | 5 | 180 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 2.21e-06 | 5 | 180 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 2.21e-06 | 5 | 180 | 3 | C0033804 | |
| Disease | Disorders of Sex Development | 7.67e-06 | 7 | 180 | 3 | C0036875 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 9.80e-06 | 80 | 180 | 6 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Alzheimer disease | 1.22e-05 | 8 | 180 | 3 | cv:C0002395 | |
| Disease | Acute Confusional Senile Dementia | 3.32e-05 | 99 | 180 | 6 | C0546126 | |
| Disease | Alzheimer Disease, Late Onset | 3.32e-05 | 99 | 180 | 6 | C0494463 | |
| Disease | Alzheimer's Disease, Focal Onset | 3.32e-05 | 99 | 180 | 6 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 3.32e-05 | 99 | 180 | 6 | C0750901 | |
| Disease | Presenile dementia | 3.32e-05 | 99 | 180 | 6 | C0011265 | |
| Disease | Familial Alzheimer Disease (FAD) | 3.51e-05 | 100 | 180 | 6 | C0276496 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 3.70e-05 | 2 | 180 | 2 | C1839840 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 3.70e-05 | 2 | 180 | 2 | cv:C1839840 | |
| Disease | 46,XY SEX REVERSAL 8 | 3.70e-05 | 2 | 180 | 2 | 614279 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 3.70e-05 | 2 | 180 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | neurofibroma | 3.70e-05 | 2 | 180 | 2 | C0027830 | |
| Disease | Alzheimer's Disease | 3.72e-05 | 101 | 180 | 6 | C0002395 | |
| Disease | obesity (is_marker_for) | 3.72e-05 | 101 | 180 | 6 | DOID:9970 (is_marker_for) | |
| Disease | Endometrial Carcinoma | 8.03e-05 | 72 | 180 | 5 | C0476089 | |
| Disease | Coronary Artery Vasospasm | 1.11e-04 | 3 | 180 | 2 | C0010073 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.11e-04 | 3 | 180 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.11e-04 | 3 | 180 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Global developmental delay | 1.71e-04 | 133 | 180 | 6 | C0557874 | |
| Disease | cocaine use disorder | 2.20e-04 | 4 | 180 | 2 | EFO_0010445 | |
| Disease | Melanocytic nevus | 2.20e-04 | 4 | 180 | 2 | C0027962 | |
| Disease | Schwannomatosis, Plexiform | 3.66e-04 | 5 | 180 | 2 | C0751374 | |
| Disease | Perineurioma | 3.66e-04 | 5 | 180 | 2 | C0751691 | |
| Disease | Nerve Sheath Tumors | 3.66e-04 | 5 | 180 | 2 | C0206727 | |
| Disease | Peripheral Nerve Sheath Neoplasm | 3.66e-04 | 5 | 180 | 2 | C0751689 | |
| Disease | Arteriosclerosis | 3.66e-04 | 5 | 180 | 2 | C0003850 | |
| Disease | Endometrioid carcinoma ovary | 3.66e-04 | 5 | 180 | 2 | C0346163 | |
| Disease | Endometrial Neoplasms | 4.39e-04 | 58 | 180 | 4 | C0014170 | |
| Disease | cortolone glucuronide (1) measurement | 5.46e-04 | 6 | 180 | 2 | EFO_0800552 | |
| Disease | prostate cancer | 5.46e-04 | 6 | 180 | 2 | MONDO_0008315 | |
| Disease | Neurilemmoma | 5.46e-04 | 6 | 180 | 2 | C0027809 | |
| Disease | Mental deterioration | 7.26e-04 | 29 | 180 | 3 | HP_0001268 | |
| Disease | Bipolar Disorder | 7.37e-04 | 477 | 180 | 10 | C0005586 | |
| Disease | level of Sterol ester (27:1/22:6) in blood serum | 7.62e-04 | 7 | 180 | 2 | OBA_2045201 | |
| Disease | angle-closure glaucoma (is_implicated_in) | 7.62e-04 | 7 | 180 | 2 | DOID:13550 (is_implicated_in) | |
| Disease | Goiter | 7.62e-04 | 7 | 180 | 2 | C0018021 | |
| Disease | Early-onset autosomal dominant Alzheimer disease | 7.62e-04 | 7 | 180 | 2 | cv:CN043596 | |
| Disease | cocaine use disorder, social environment measurement | 1.01e-03 | 8 | 180 | 2 | EFO_0010445, EFO_0010552 | |
| Disease | lateral ventricle volume measurement | 1.06e-03 | 33 | 180 | 3 | EFO_0008487 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.06e-03 | 33 | 180 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | retinal degeneration (implicated_via_orthology) | 1.06e-03 | 33 | 180 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.15e-03 | 261 | 180 | 7 | C0004352 | |
| Disease | Antihypertensive use measurement | 1.26e-03 | 265 | 180 | 7 | EFO_0009927 | |
| Disease | Prostatic Cancer, Castration-Resistant | 1.30e-03 | 9 | 180 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 1.30e-03 | 9 | 180 | 2 | C3658267 | |
| Disease | Alcoholic Intoxication, Chronic | 1.34e-03 | 268 | 180 | 7 | C0001973 | |
| Disease | Cardiovascular Diseases | 1.37e-03 | 36 | 180 | 3 | C0007222 | |
| Disease | Behcet's disease (is_implicated_in) | 1.37e-03 | 36 | 180 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | Depression, Bipolar | 1.41e-03 | 79 | 180 | 4 | C0005587 | |
| Disease | myocardial infarction | 1.45e-03 | 350 | 180 | 8 | EFO_0000612 | |
| Disease | colorectal health | 1.51e-03 | 201 | 180 | 6 | EFO_0008460 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.61e-03 | 10 | 180 | 2 | C1631597 | |
| Disease | Autism Spectrum Disorders | 1.85e-03 | 85 | 180 | 4 | C1510586 | |
| Disease | Tachycardia, Ventricular | 1.96e-03 | 11 | 180 | 2 | C0042514 | |
| Disease | Back pain | 2.01e-03 | 87 | 180 | 4 | HP_0003418 | |
| Disease | platelet crit | ANKRD31 DNAH3 AHI1 DOCK10 RICTOR APOE PDE10A PXK RCOR1 NF1 DQX1 SYK ELF1 SLC25A11 | 2.20e-03 | 952 | 180 | 14 | EFO_0007985 |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 2.35e-03 | 12 | 180 | 2 | DOID:3319 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 2.56e-03 | 93 | 180 | 4 | C1535926 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 2.62e-03 | 45 | 180 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 2.76e-03 | 13 | 180 | 2 | DOID:10941 (biomarker_via_orthology) | |
| Disease | Congenital Hypothyroidism | 2.76e-03 | 13 | 180 | 2 | C0010308 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.76e-03 | 13 | 180 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | red blood cell density measurement | DNAH10 SIAH1 RICTOR CHD4 ACAD10 INO80 DPP8 PDE10A ABCC6 PXK FARP2 AK1 EMP2 | 3.02e-03 | 880 | 180 | 13 | EFO_0007978 |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 3.21e-03 | 14 | 180 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | orotic acid measurement | 3.21e-03 | 14 | 180 | 2 | EFO_0010516 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.21e-03 | 14 | 180 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | eating disorder, bipolar disorder | 3.21e-03 | 14 | 180 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | multiple sclerosis (is_marker_for) | 3.35e-03 | 49 | 180 | 3 | DOID:2377 (is_marker_for) | |
| Disease | diabetic retinopathy (is_implicated_in) | 3.54e-03 | 50 | 180 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | thrombosis (is_implicated_in) | 3.69e-03 | 15 | 180 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | response to tenofovir | 3.75e-03 | 51 | 180 | 3 | EFO_0009279 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CTTNBP2 ARHGAP15 NOL6 DOCK10 NCAM1 NBEA RYR2 RANBP17 SLIT2 UBA7 ADGRL2 KCNAB3 | 3.88e-03 | 801 | 180 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | COVID-19, mortality | 3.97e-03 | 170 | 180 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 4.20e-03 | 16 | 180 | 2 | C0334634 | |
| Disease | atherosclerosis (is_implicated_in) | 4.20e-03 | 16 | 180 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | response to methotrexate | 4.20e-03 | 16 | 180 | 2 | GO_0031427 | |
| Disease | melanoma | 4.28e-03 | 248 | 180 | 6 | C0025202 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 4.64e-03 | 335 | 180 | 7 | EFO_0009931 | |
| Disease | phenylalanine measurement | 4.64e-03 | 55 | 180 | 3 | EFO_0005001 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 4.74e-03 | 17 | 180 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Lipidemias | 4.74e-03 | 17 | 180 | 2 | C1706412 | |
| Disease | pre-eclampsia (biomarker_via_orthology) | 4.74e-03 | 17 | 180 | 2 | DOID:10591 (biomarker_via_orthology) | |
| Disease | Moyamoya Disease | 4.74e-03 | 17 | 180 | 2 | C0026654 | |
| Disease | Hyperlipidemia | 4.74e-03 | 17 | 180 | 2 | C0020473 | |
| Disease | coronary artery disease, factor VII measurement | 4.83e-03 | 111 | 180 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | Alzheimer's disease (is_marker_for) | 5.08e-03 | 257 | 180 | 6 | DOID:10652 (is_marker_for) | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 5.13e-03 | 57 | 180 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | factor VIII measurement, coronary artery disease | 5.15e-03 | 113 | 180 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Beta blocking agent use measurement | 5.31e-03 | 114 | 180 | 4 | EFO_0009929 | |
| Disease | Age-related macular degeneration | 5.31e-03 | 18 | 180 | 2 | cv:C0242383 | |
| Disease | Tourette syndrome, schizophrenia | 5.31e-03 | 18 | 180 | 2 | EFO_0004895, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALRYQLQRGVVVLAK | 256 | P17516 | |
| YKSGEQILRLANERF | 261 | Q9GZN1 | |
| ALNRYIGVRILEQDK | 541 | Q7L0X2 | |
| YYQRGILAKVEGQRL | 271 | P32519 | |
| DDLQKRLAVYQAGAR | 171 | P02649 | |
| IDIQNGFLLRYAVIK | 176 | Q9H672 | |
| LLRNLAREGANYALV | 211 | O43505 | |
| ILVARKFVGAANYRE | 831 | Q8N157 | |
| ALRYQLQRGVVVLAK | 256 | P42330 | |
| VVRQYLARFLEGLAL | 211 | Q7L3V2 | |
| RVDLANLYIRTGAKN | 2891 | Q96DT5 | |
| FRVAAILQGVYKRSL | 556 | Q6JQN1 | |
| RALVADFVGYKLRQK | 11 | Q92843 | |
| QLSGLEKRFEIQRYL | 121 | Q3C1V8 | |
| QNSRNGLAKLVFIIY | 706 | O95490 | |
| NGYRLGERVLQVSFK | 346 | Q14576 | |
| KDFKIRLQYFARGLQ | 371 | Q9BZZ5 | |
| RATFQAYQILIGKDI | 206 | P27216 | |
| INLRQLYGDSRKFLL | 336 | Q9BSQ5 | |
| DGKNLRLYQAVVDAR | 786 | Q8TDJ6 | |
| AQQTLYFGEKRALRD | 66 | Q8N126 | |
| YFGEKRALRDNRIQL | 71 | Q8N126 | |
| VYRGLLADFQALLRA | 171 | Q9NVE4 | |
| FLLLVKGQQADLARY | 321 | Q9HBB8 | |
| IQRRFKDTIINAKYG | 421 | Q7L5Y6 | |
| GNALLVYRVFRNEAK | 66 | P49447 | |
| AFDVLVLRYGVQKRI | 781 | Q8IYB7 | |
| EGIQFLVTRYIKALN | 1111 | Q6DHV5 | |
| DVLVLRNLTKVYRGQ | 1791 | Q8IZY2 | |
| VQRAAQYLKVEQLFG | 986 | Q07912 | |
| FLRAQYEGLKRQQRT | 41 | Q5JTZ5 | |
| QLLAVQAIRKYGRDF | 391 | Q9UKL0 | |
| EQLLAVQAIRRYGKD | 336 | Q8IZ40 | |
| RFLARLKTNYQLGEL | 331 | Q9H2T7 | |
| AAIDYTQLGLRFKLQ | 106 | Q86UR1 | |
| RAKAGYNVKQLFRRV | 156 | Q9H0N0 | |
| RAKAGYNVKQLFRRV | 156 | Q53S08 | |
| LRIFKNGNVLYSIRL | 151 | O75311 | |
| LKLADVFRVGNNFLR | 66 | Q9NVH2 | |
| QRYLRNKDFLLGVNF | 941 | Q9ULG1 | |
| LRAARAGNLDKVVEY | 36 | Q01484 | |
| AFEVAYQLALQARKG | 1181 | Q7Z6G8 | |
| SINRRNIFGENLVYK | 481 | Q8N7Z5 | |
| RALLQKYADIDIRGQ | 286 | Q9ULH0 | |
| NKLRNIRYGFNTILV | 461 | Q8WVX9 | |
| DLINKRRRDGYLFQL | 36 | P04196 | |
| NNIAIKGVARFYRSR | 131 | Q9Y697 | |
| AYQGVLVELARANRL | 686 | Q9UBB6 | |
| GKFQLVAENRRYQRS | 41 | P19823 | |
| IAFYEKRGIVRKVNA | 161 | P00568 | |
| KFLIRARDNNGSYAL | 191 | P43405 | |
| QKLDFRLQQGAYRLL | 3796 | Q8NDA2 | |
| EKAAREYRVNAQGLL | 316 | Q8NHP7 | |
| EFCQLGDLKRYLRAQ | 211 | Q96Q04 | |
| YDNREKRAFLLGSVQ | 191 | Q53TS8 | |
| RGFLAQKLQQYKRFV | 1021 | Q9NRD8 | |
| TYALQVARRNLQGIK | 2001 | Q5CZC0 | |
| NQVVGLVTRKDLARY | 776 | P51798 | |
| AGKEREYQALVQRAL | 1181 | O95382 | |
| NVFQKGIYLLRVQAS | 296 | P17181 | |
| QAAARGYLARRAFQK | 811 | Q7Z406 | |
| RVNGRNIVKANFTIY | 686 | Q9Y4D7 | |
| RNQGLYRLGNFLFIL | 271 | Q9HB15 | |
| IATDLALYFGNRKQL | 621 | Q9Y233 | |
| REILQDKDGLNQRYF | 186 | Q9H6R4 | |
| RAVGKLSYNQLVERI | 251 | Q8N5J2 | |
| DQRNGLRVIYKLLAS | 716 | P50851 | |
| KYRIQRGALILSNVQ | 381 | P32004 | |
| FRLKYENELALRQGV | 191 | P19012 | |
| QRQAIKGAFYRRAQR | 31 | Q9UIX4 | |
| RLGRATQNYKNLLLF | 131 | Q6JVE6 | |
| QGLKDVLLTAFAYRQ | 201 | O15287 | |
| VIQRANLAYGDFIKS | 531 | Q9BZ72 | |
| RFGIAVLGYLNRNAL | 306 | P17301 | |
| DAFGYATLKRLQQQR | 1326 | Q6R327 | |
| QNRRDLQKALVSGYF | 586 | Q8TE96 | |
| RLQFGVAVIDNKLYV | 466 | Q9C0H6 | |
| QLEEARKAGQELRFY | 231 | Q8N485 | |
| DQRRGYKNVFNALIR | 156 | Q02978 | |
| AAEDLFVNIRGYNKR | 306 | Q9Y2A7 | |
| FVNIRGYNKRINDIR | 311 | Q9Y2A7 | |
| RNIRLVQFYIQIGSK | 1501 | P78509 | |
| YRVSGNLAVIQKLRF | 691 | Q8IWW6 | |
| AQSYAQQLGRLFRKA | 531 | P29474 | |
| KRQRYRLSAQAEGLQ | 731 | P29474 | |
| RFLFGIYQQAEKARL | 241 | P11117 | |
| RAAIEREYGQALQKL | 46 | Q86WN1 | |
| LQALNDRFAGYIDKV | 101 | P12036 | |
| IFVLQLFRLKQGERF | 81 | P54851 | |
| VARVYNGRLKVQRLC | 31 | P57076 | |
| RDNYDQLVRIAKFLG | 236 | Q8NEV1 | |
| QAKEGDLQRVLLYVR | 506 | Q8TE85 | |
| GLDIKLNTAVRQVRY | 581 | O60341 | |
| KARITQRALDYGVQA | 31 | Q8NFQ6 | |
| GVVQNNRLRKYAFEL | 246 | Q96BY6 | |
| ILDVCLQNFRYLGKR | 1371 | Q96BY6 | |
| RSRILFNQLYENKGE | 751 | Q14185 | |
| RNRYLTGLQKLDFAA | 2676 | Q8TD57 | |
| RKEVFIQERYGRFNL | 66 | Q8WZ74 | |
| QLEDRNKRFISIYRG | 996 | Q53EP0 | |
| NYKGLVRAATVREQL | 571 | Q9H5Z1 | |
| ARAIYRKYILDNNGI | 141 | O15169 | |
| LVNNRFKGVKYFRLN | 676 | Q6V1X1 | |
| LGVAALYKFRVADQR | 31 | P09669 | |
| KARGQNVTIFYVNRL | 81 | Q2M3T9 | |
| FYKNGIKERFQITRI | 66 | Q5VWK5 | |
| IAVRRAAQVFYNNKG | 1721 | Q9BZC7 | |
| FYIVKGNRKEAARIA | 41 | Q8WWX0 | |
| YYQRGILAKVEGQRL | 271 | Q15723 | |
| KGQQRRYFIAAEKIL | 376 | Q6MZM0 | |
| QVLVFYTKLLGRIRQ | 106 | Q5W0V3 | |
| GRRYAINLDVQKEAI | 371 | Q6SJ93 | |
| AEILRFNYKIRLVGD | 456 | Q16099 | |
| AAVENQLSGYLLRKF | 926 | O94887 | |
| ALDERVGYARILFKN | 361 | O95479 | |
| GQLRELEREYAANKF | 226 | Q92826 | |
| ANGEVRIYRDKALLN | 351 | Q8NFJ9 | |
| IEVLGFNARQRKAFL | 1411 | Q14839 | |
| LQEDKFLRYTAGIQR | 696 | Q8IVF4 | |
| IEKRFAFGFLQQLLR | 2951 | P21817 | |
| DILKFLQINGYAVSR | 2891 | Q92736 | |
| NAKGVILNAFERYRL | 86 | Q16820 | |
| VRARKQIVAGVNYFL | 76 | P01034 | |
| YLRRSGIGNVFIKNL | 91 | P0CB38 | |
| RLAGDKYQAAVQALR | 451 | P34896 | |
| ERLQLGYVDIVFANR | 186 | O43448 | |
| IRQLNLYGFRKVVLG | 81 | Q4G112 | |
| LYGNIFLVARRQAKK | 216 | Q96RI8 | |
| QRLGFYASLLKRQLN | 6 | Q15031 | |
| LLAQKGLFYRLAQES | 1486 | O95255 | |
| ANEFKVRRIKLGYTQ | 136 | P28069 | |
| FRQQLYGIKTRDAIL | 56 | Q9H1U9 | |
| FDQRNGIRVIYKLLA | 741 | Q8NFP9 | |
| FYVGKDRKQNRLVIV | 51 | Q9NXP7 | |
| NLLLSVKYGRFQGQR | 816 | P58107 | |
| YRVSGNLATIQKLRF | 316 | Q53QZ3 | |
| LKFLYKRGANVNLRR | 141 | Q05823 | |
| LIGTRKQAENFAYRL | 211 | Q8IUQ4 | |
| LIGTRKQAENFAYRL | 251 | O43255 | |
| AKSYLRALNRAQEVG | 856 | Q8TF17 | |
| FRQQLYGIKTRDAVL | 56 | Q3SY17 | |
| AYRKGIILFISRNRQ | 136 | Q9Y399 | |
| IDAFQRAAGVLNYLK | 246 | Q8IUC4 | |
| LDRQLIRLCQKFGEY | 546 | Q15436 | |
| GQKELVVGARNYLFR | 66 | Q13591 | |
| VVGARNYLFRLQLED | 71 | Q13591 | |
| ALLEQDAFRQLIYGR | 981 | Q8N961 | |
| RNLLSVAYKNVVGAR | 41 | P63104 | |
| ALRYQLQRGVVVLAK | 256 | Q04828 | |
| ALRYQLQRGVVVLAK | 256 | P52895 | |
| QAALAVLLYRAAGQR | 206 | Q8NE01 | |
| EGRYLFLNAIANQLR | 2261 | A5YKK6 | |
| FIVLSNNYLQIRGIK | 166 | P13591 | |
| LQKGEFILATRGLRY | 351 | Q9H6R6 | |
| GQNVKLRYFLRATIS | 121 | Q4G0F5 | |
| NYRNLVFLGIAVSKL | 36 | A8MXY4 | |
| YQRAFNEFLERGKQL | 401 | Q03169 | |
| NEFLERGKQLTNYRA | 406 | Q03169 | |
| YEDAIQFIRQKRRGA | 126 | O75365 | |
| LIRNARYAEAVQLLG | 21 | Q8N4P2 | |
| GRLNLEEFQQLYVKF | 41 | P62760 | |
| LAFQKGIRNKVYQRF | 2641 | Q8IZQ1 | |
| GKRLEDALRAQQFYR | 1581 | O15020 | |
| RDINSVAGVLKLYFR | 571 | O43295 | |
| GFDAIRVYNKRLKAL | 571 | O43511 | |
| YFNRRIIGALVDQAV | 606 | Q0IIM8 | |
| FQEKLRRQHYLLVGA | 426 | P41226 | |
| AAGLLDQFYEKQRLL | 331 | O60687 | |
| VFDKNRRLQLLDGEY | 301 | Q15022 | |
| RRFKTGQINGDLLIY | 1611 | P21359 | |
| REFIAERQKGLQNYL | 86 | Q7Z7A4 | |
| LVLKNGVLAYIGNFR | 131 | Q96MV1 | |
| IYRVSGNLAVVQKLR | 576 | Q9BRR9 | |
| AFRGAVDIKNLQLDY | 146 | O94813 | |
| IDAFQRAAGVLNYLK | 161 | A8MT19 | |
| AQLEQVYIRGSKIRF | 56 | P62318 | |
| REGDNRYLQLFKNLL | 636 | Q9NYK1 | |
| NYRNLVFLGIAVSKQ | 36 | Q8TD23 | |
| IFIIFYQGEQLRQKI | 221 | Q9HBG4 | |
| AVYLRALVRNLFNEG | 36 | Q8IWR0 | |
| KIAVNIALERFRYGD | 46 | Q9H6S0 | |
| FRNQKILREYRDFLG | 206 | Q6PML9 | |
| KEFLQLIGYSNFQRV | 711 | O15041 | |
| IRNILFGAVRGLNYL | 161 | Q9C0K7 | |
| ARIRLSFAQVYQGQK | 186 | Q5W5X9 | |
| LFNLGSKVLRQYLDA | 401 | Q5H8A4 | |
| LGKRTRFQENYVAQL | 271 | Q6P3X3 | |
| YEDAVQFIRQKRRGA | 126 | Q93096 | |
| NVIYLEVQKGQFLRL | 271 | Q96RL6 | |
| LKNAIIIQSFIRGYR | 46 | Q15386 | |
| IIQSFIRGYRDRKQQ | 51 | Q15386 | |
| GLLNQNFRKEYRRII | 296 | P48039 |